Gd(III)-nanodiamond conjugates for MRI contrast enhancement

Area of Science:

• Nanomaterials Science
• Biomedical Imaging
• Radiochemistry

Background:

• Gadolinium(III) complexes are widely used as MRI contrast agents.
• Improving the relaxivity of Gadolinium(III) agents is crucial for enhanced MRI sensitivity.
• Nanodiamonds offer a unique platform for developing novel biomedical materials.

Purpose of the Study:

• To synthesize and characterize a Gadolinium(III)-nanodiamond conjugate (Gd(III)-ND).
• To evaluate the potential of Gd(III)-ND as an MRI contrast agent.
• To compare the relaxivity of Gd(III)-ND with monomeric Gd(III) complexes.

Main Methods:

• Synthesis of Gd(III)-nanodiamond conjugate.
• Characterization using appropriate analytical techniques.
• Relaxivity measurements at 1.5 T (60 MHz).

Main Results:

• Successful preparation and characterization of Gd(III)-ND.
• Gd(III)-ND significantly reduced the T(1) of water protons.
• Achieved a per-Gd(III) relaxivity of 58.82 +/- 1.18 mM(-1) s(-1).
• Demonstrated a 10-fold increase in relaxivity compared to monomer Gd(III) complexes.

Conclusions:

• Gd(III)-ND conjugates are effective for MR imaging detection of nanodiamonds.
• The high per-Gd(III) relaxivity of Gd(III)-ND offers superior performance.
• This conjugate represents a promising advancement in MRI contrast agent development.